RFK Jr. pushes peptide deregulation; FDA scientists cite lack of safety evidence
By
Aria Bendix
Summary
Health Secretary Robert F. Kennedy Jr. is pushing to deregulate several peptides, making them more accessible through compounding pharmacies. However, FDA scientists argue there is insufficient evidence on the safety and effectiveness of these molecules, with some never having been studied in humans. The FDA is set to present its findings at an upcoming advisory committee meeting to assess whether compounding pharmacies should be allowed to produce seven specific peptides.
Source
Key quotes
· 3 pulledHealth Secretary Robert F. Kennedy Jr. has advocated for deregulating a number of peptides, but scientists at the Food and Drug Administration say there's insufficient evidence to recommend their use.
The FDA scientists are set to present their conclusions next month at an FDA advisory committee meeting that will assess whether to allow compounding pharmacies to produce seven different peptides.
Some have not been studied in humans.
You might also wanna read
Collapse of the FDA Under New Health Secretary
The article discusses the collapse of the FDA under the new health secretary, Robert F. Kennedy Jr., who is accused of dismantling the agenc
FDA PCAC Hearing July 2026: What's at Stake for Compounded Peptide Access
This article covers the upcoming July 23-24, 2026 FDA Pharmacy Compounding Advisory Committee (PCAC) hearing on peptides nominated for the 5

HHS Secretary Kennedy Calls for Deprescribing Psychiatric Medications, Sparking Debate on Overprescription
This article examines HHS Secretary Robert F. Kennedy Jr.'s call to deprescribe psychiatric medications "when clinically indicated," made at
FDA Announces Loosened Restrictions on Synthetic Peptide Use in Children
The FDA announces it has loosened restrictions on dousing children with synthetic peptides, with the commissioner stating that while the eff
RFK Jr Demands Retraction of Vaccine Study Finding No Aluminum-Disease Link
US health secretary and vaccine skeptic Robert F. Kennedy Jr has called for the retraction of a Danish study that found no link between alum
Inside the Grey Market Peptide Economy: Regulatory Gaps and Underground Pharmaceutical Infrastructure
This article investigates the parallel pharmaceutical infrastructure built around grey market peptides like BPC-157 and semaglutide. It cont

Comments
Sign in to join the conversation.
No comments yet. Be the first.